Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Poised to address unmet need in neuromuscular diseases and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Jul 21, 2026
Document Date
Jul 21, 2026
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.